CFN Media Group issued an article showcasing Medical Marijuana Inc (OTCMKTS:MJNA) recent invitation to talk to the United Nations at the WHO and how that entity’s decisions could pave the way to marketing Cannabidiol as a supplement rather than as a prescription medication.
Cannabidiol, the key ingredient in Medical Marijuana products, has been rising in popularity due to its remarkable potential to treat numerous grave medical conditions. In fact, the CBD has demonstrated promise in curing everything from antibiotic resistant infections to arthritis to schizophrenia. The issue is that regulators still cure CBD such as its psychoactive cousin, tetrahydrocannabinol which results in a “high” for users.
Medical Marijuana’s HempMeds® subsidiary unit has advanced major CBD offerings under the Real Scientific Hemp Oil brand name. As a CBD hemp oil that has between 10% and 30% Cannabidiol content, the offering has quickly become a major source of medical-grade Cannabidiol oil for people in need across the globe, including Mexico, Puerto Rico, Brazil and throughout the U.S.
HempMeds Mexico marks as the first firm to offer Mexican citizens with access to medicinal offerings derived from cannabis after COFEPRIS, issued the nation’s first-ever import permits for RSHO-X™ in early 2016. The firm has made similar advancements in Brazil, where it turned the first firm to import CBD oil into the nation.
In Mexico, the firm’s offerings have also been utilized in clinical studies assessing the efficacy of Cannabidiol in treating numerous conditions. One study showed that RSHO-X-5000 lowered motor seizures for 84% of subjects with Lennox Gastaut Syndrome, a grave form of childhood encephalopathies.
Dr. Stuart Titus, the CEO of Medical Marijuana, expressed that they are excited and honored to speak to United Nations leaders on an international stage about Cannabidiol as a supplement intended to maintain and enhance the wellbeing of millions. They hope to throw light on the several advantages of Cannabidiol and convince decision-makers that Cannabidiol in its natural botanical state, fetched from hemp, should be termed as a supplement.